Sign Up to like & get
recommendations!
0
Published in 2019 at "Experimental Hematology"
DOI: 10.1016/j.exphem.2019.06.411
Abstract: Precursor-B acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy. Relapsed disease has a poor prognosis despite improved outcomes with tyrosine kinase inhibitors (TKIs) and immunotherapeutic approaches such as CAR-T cells. Targeting cell survival with…
read more here.
Keywords:
bh3 mimetic;
acute lymphoblastic;
bh3;
lymphoblastic leukemia ... See more keywords